Immuniseringsprogrammet bør tilpasses for at sikre, at anti- HB antistoftiteren forbliver over det anerkendte beskyttende niveau på 10 IU/ l.
The immunisation schedule should be adapted in order to ensure that the anti-HBs antibody titre remains above the accepted protective level of 10 IU/ l.